FDA — authorised 24 October 1978
- Application: NDA012259
- Marketing authorisation holder: PHARMACIA AND UPJOHN
- Local brand name: ALPHADROL
- Indication: TABLET — ORAL
- Status: approved
🇺🇸 Dexamethasone+NK-1 RA+5-HT3 RA in United States
FDA authorised Dexamethasone+NK-1 RA+5-HT3 RA on 24 October 1978
Marketing authorisation
Frequently asked questions
Is Dexamethasone+NK-1 RA+5-HT3 RA approved in United States?
Yes. FDA authorised it on 24 October 1978.
Who is the marketing authorisation holder for Dexamethasone+NK-1 RA+5-HT3 RA in United States?
PHARMACIA AND UPJOHN holds the US marketing authorisation.